{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:51:55Z","timestamp":1790031115326,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.jaci.2004.11.054","type":"journal-article","created":{"date-parts":[[2005,4,2]],"date-time":"2005-04-02T07:14:54Z","timestamp":1112426094000},"page":"848-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Predictors of immunologic long-term nonprogression in HIV-infected children: Implications for initiating therapy"],"prefix":"10.1016","volume":"115","author":[{"given":"Mary E.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhattan","family":"Charurat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Serchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Foca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.11.054_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/aid.1992.8.435","article-title":"Biological markers associated with prolonged survival in African children maternally infected by the human immunodeficiency virus type 1","volume":"8","author":"Van de Pere","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaci.2004.11.054_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1542\/peds.95.5.657","article-title":"Older children and adolescents with perintally acquired human immunodeficiency virus infection","volume":"95","author":"Grubman","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.11.054_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1089\/aid.1996.12.1565","article-title":"Workshop on perinatally acquired human immunodeficiency virus infection in long-term surviving children: a collaborative study of factors contributing to slow disease progression","volume":"12","author":"Martin","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaci.2004.11.054_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/aid.1996.12.1063","article-title":"Immunological correlates of disease severity in pediatric slow progressors with human immunodeficiency virus type 1 infection","volume":"12","author":"Patarca","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaci.2004.11.054_bib5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.99.4.e4","article-title":"A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors","volume":"99","author":"Nielsen","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.11.054_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0198-8859(97)00092-X","volume":"55","author":"Chen","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/108729101300003645","article-title":"Follow-up of vertically HIV-1-infected long-surviving children","volume":"15","author":"Salvini","year":"2001","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.jaci.2004.11.054_bib8","first-page":"350","article-title":"Characteristics of children surviving to 5 years of age or older with vertically acquired HIV infection","volume":"6","author":"Kline","year":"1995","journal-title":"Pediatric AIDS HIV Infect"},{"key":"10.1016\/j.jaci.2004.11.054_bib9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1089\/08892220050195810","article-title":"Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors","volume":"16","author":"Geffin","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaci.2004.11.054_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00042560-199712010-00003","article-title":"CCR5del32 in perinatal HIV-1 infection","volume":"16","author":"Rousseau","year":"1997","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirology"},{"key":"10.1016\/j.jaci.2004.11.054_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/CDLI.5.1.38-40.1998","article-title":"Distribution of CCR5\u039432 in human immunodeficiency virus-infected children and its relationship to disease course","volume":"5","author":"Bakshi","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.279.4.277","article-title":"CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children","volume":"279","author":"Misrahi","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.11.054_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/515660","article-title":"Impact of heterozygosity for the chemokine receptor CCR5-32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age","volume":"178","author":"Buseyne","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2004.11.054_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF03401932","article-title":"Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection","volume":"6","author":"Romiti","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.jaci.2004.11.054_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2004.11.054_bib16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","article-title":"Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent, viral load, and age","volume":"362","author":"Dunn","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.11.054_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/516441","volume":"175","author":"Mofenson","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2004.11.054_bib18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM199705083361901","article-title":"Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group","volume":"336","author":"Shearer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.11.054_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/515596","article-title":"Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group","volume":"178","author":"Abrams","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2004.11.054_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3476(95)70357-8","article-title":"Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants","volume":"126","author":"Palumbo","year":"1995","journal-title":"J Pediatr"},{"issue":"suppl","key":"10.1016\/j.jaci.2004.11.054_bib21","first-page":"S95","article-title":"Long-term survivors of HIV-1 infection: definitions and research challenges","volume":"8","author":"Schrager","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2004.11.054_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.990140703","article-title":"Guideline for flow cytometric immunophenotyping: A report from the National Institute of Allergy and Infectious Diseases, Division of AIDS","volume":"14","author":"Calvelli","year":"1993","journal-title":"Cytometry"},{"key":"10.1016\/j.jaci.2004.11.054_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0090-1229(89)90194-3","article-title":"Results of the flow cytometry ACTG quality control program: analysis and findings","volume":"52","author":"Paxton","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.11.054_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/clin.1993.1019","article-title":"Assessment of the effects of instrumentation, monoclonal antibody and fluorochrome on flow cytometric immunophenotyping: a report based on two years of the NIAID DAIDS Flow Cytometry Quality Assessment Program","volume":"66","author":"Gelman","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.11.054_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/clin.1997.4439","article-title":"Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection","volume":"85","author":"Rich","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.11.054_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","article-title":"Basic principles of ROC analysis","volume":"8","author":"Metz","year":"1978","journal-title":"Semin Nucl Med"},{"issue":"No. RR-12","key":"10.1016\/j.jaci.2004.11.054_bib27","first-page":"1","article-title":"1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.11.054_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0090-1229(89)90196-7","article-title":"Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco","volume":"52","author":"Stites","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.11.054_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.1992.tb05854.x","article-title":"The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value","volume":"90","author":"Levacher","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib30","first-page":"904","article-title":"Elevated levels of CD38+CD8+T cells in HIV infection add to the prognostic value of low CD4+ T cell levels; results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study","volume":"6","author":"Giorgi","year":"1993","journal-title":"J AIDS"},{"key":"10.1016\/j.jaci.2004.11.054_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/170.4.775","article-title":"CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+CD38-CD8+ cells is associated with subsequent stable CD4+cell levels","volume":"170","author":"Giorgi","year":"1994","journal-title":"J Infect Ds"},{"key":"10.1016\/j.jaci.2004.11.054_bib32","first-page":"158","article-title":"CD8+CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1 infected patients","volume":"14","author":"Mocroft","year":"1997","journal-title":"J AIDS"},{"key":"10.1016\/j.jaci.2004.11.054_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199001183220305","article-title":"The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1","volume":"322","author":"Fahey","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.11.054_bib34","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00002030-199813000-00004","article-title":"Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements","volume":"12","author":"Fahey","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2004.11.054_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00042560-199808010-00004","article-title":"CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency","volume":"18","author":"Liu","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirology"},{"key":"10.1016\/j.jaci.2004.11.054_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00042560-199710010-00003","volume":"16","author":"Liu","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirology"},{"key":"10.1016\/j.jaci.2004.11.054_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jama.284.2.223","article-title":"Immune restoration with antiretroviral therapies: implications for clinical management","volume":"284","author":"Lederman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.11.054_bib38","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set-point during early HIV infection predicts subsequent CD4+ T cell changes independent of viral load","author":"Deeks","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.11.054_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1024536816684","article-title":"Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children","volume":"23","author":"Resino","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib40","first-page":"20","article-title":"CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection","volume":"7","author":"Aldhous","year":"1996","journal-title":"Pediatr AIDS HIV Infect"},{"key":"10.1016\/j.jaci.2004.11.054_bib41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1203\/00006450-200206000-00013","article-title":"CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients","volume":"51","author":"Sherman","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2004.11.054_bib42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/mai.2001.117179","article-title":"Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non\u2013rapid progressor children","volume":"108","author":"Paul","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cyto.1100","article-title":"Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets","volume":"46","author":"McCloskey","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.jaci.2004.11.054_bib44","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.4049\/jimmunol.162.6.3680","article-title":"Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children","volume":"162","author":"Than","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/clin.1994.1046","article-title":"T-cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping","volume":"71","author":"Plaeger-Marshall","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.11.054_bib46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.11.054_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/clin.1997.4370","article-title":"Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children, and adults","volume":"84","author":"McCloskey","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.11.054_bib48","first-page":"1","article-title":"The immune system","volume":"Vol. I","author":"Shearer","year":"2003"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674905000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674905000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:57:40Z","timestamp":1758776260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674905000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0091674905000291"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.11.054","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of immunologic long-term nonprogression in HIV-infected children: Implications for initiating therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.11.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}